Impaired awareness of hypoglycaemia: A new risk factor for adverse pregnancy outcomes in type 1 diabetes

被引:9
|
作者
Perea, Veronica [1 ]
Bertran, Berta [2 ]
Bellart, Jordi [3 ]
Orois, Aida [1 ,4 ]
Gimenez, Marga [4 ]
Conget, Ignacio [4 ]
Vinagre, Irene [4 ]
机构
[1] Hosp Univ Mutua Terrassa, Dept Endocrinol, 5 Doctor Robert Sq, Barcelona 08221, Spain
[2] Univ Barcelona, Univ Sch Nursing, Barcelona, Spain
[3] Hosp Clin Barcelona, Obstet & Gynecol Dept, Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Endocrinol, Diabet Unit, 170 Villarroel St, E-08036 Barcelona, Spain
关键词
impaired awareness of hypoglycaemia; pregnancy; type; 1; diabetes; PLASMA-LIPOPROTEINS; MOUSE EMBRYOS; WOMEN; PREECLAMPSIA; FETAL; INFLAMMATION; PREDICTORS; METABOLISM; INCREASES; RECOVERY;
D O I
10.1002/dmrr.3176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim The aim of this study is to evaluate the impact of impaired awareness of hypoglycaemia (IAH) on metabolic control and pregnancy outcomes in women with type 1 diabetes. Material and Methods This was a single-centre prospective cohort study of singleton pregnant women with type 1 diabetes. IAH was assessed at the first antenatal visit using Clarke's test (score >= 3). Data on metabolic control, hypoglycaemic events, and the lipid profile were collected from prior to pregnancy and in each trimester of gestation. Pregnancy outcomes were also recorded. Results A total of 77 patients with type 1 diabetes were included; 24 (31.2%) were classified as having IAH. Compared with the normal awareness of hypoglycaemia (NAH) group, the IAH group did not show differences in HbA(1c), weight gain, insulin doses, or severe and nonsevere hypoglycaemia events throughout pregnancy. IAH was associated with higher triglyceride concentrations in the second trimester (IAH: 154.8 +/- 61.1 mg/dL, NAH: 128.6 +/- 31.2 mg/dL, P = .034) and an increased risk of neonatal respiratory distress (odds ratio [OR] 11.24; 95% CI, 1.01-124.9, P = .041) in adjusted models. Increased risk of pre-eclampsia was related to higher second trimester triglyceride concentrations (OR 1.028; 95% CI, 1.004-1.053, P = .023) adjusted for confounders. Conclusions The IAH was associated with increased risk of neonatal respiratory distress and pre-eclampsia, despite showing no differences in metabolic control. Hypoglycaemia awareness in the first antenatal visit should be assessed to identify the subgroup of pregnant women with increased risk of complications.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab
    McNeilly, Alison D.
    McCrimmon, Rory J.
    DIABETOLOGIA, 2018, 61 (04) : 743 - 750
  • [22] Frequency of biochemical and asymptomatic hypoglycaemia in people with Type 1 diabetes - with and without impaired awareness of hypoglycaemia
    Geddes, J.
    Wright, R. J.
    Zammitt, N. N.
    Frier, B. M.
    DIABETIC MEDICINE, 2008, 25
  • [23] Association between hypoglycaemia and impaired hypoglycaemia awareness and mortality in people with Type 1 diabetes mellitus
    Sejling, A. -S.
    Schouwenberg, B.
    Faerch, L. H.
    Thorsteinsson, B.
    de Galan, B. E.
    Pedersen-Bjergaard, U.
    DIABETIC MEDICINE, 2016, 33 (01) : 77 - 83
  • [24] Cardiac autonomic regulation during experimental hypoglycaemia in type 1 diabetes with impaired awareness of hypoglycaemia
    Walkinshaw, E.
    Little, S. A.
    Bernjak, A.
    Lubina-Solomon, A.
    Chow, E.
    Shaw, J. A. M.
    Heller, S. R.
    DIABETOLOGIA, 2015, 58 : S63 - S63
  • [25] EFFECT OF THE GLP-1 RECEPTOR AGONIST EXENATIDE ON AWARENESS OF HYPOGLYCAEMIA IN PATIENTS WITH TYPE 1 DIABETES AND IMPAIRED AWARENESS OF HYPOGLYCAEMIA
    Van Meijel, L.
    Rooijackers, H. M.
    Tack, C. J.
    de Galan, B. E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A132 - A133
  • [26] Defective involuntary attention to novelty in type 1 diabetes and impaired awareness of hypoglycaemia
    Stantonyonge, Nicole
    Martinez-Horta, Saul
    Sampedro, Frederic
    Sanchez-Saudinos, Maria Belen
    Chico, Ana
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [27] Reduced cognitive function in people with type 1 diabetes and impaired awareness of hypoglycaemia
    Bjorgaas, M. R.
    Hansen, T. I.
    Haferstrom, E. C. D.
    Olsen, S. E.
    Haberg, A. K.
    DIABETOLOGIA, 2015, 58 : S62 - S62
  • [28] Effect of treatment with dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes
    van Meijel, L. A.
    Tack, C. J.
    de Galan, B. E.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S355 - S355
  • [29] A comparison of methods used to assess impaired awareness of hypoglycaemia in Type 1 Diabetes
    Hussain, S. S.
    Ghandi, K.
    Dornhorst, A.
    DIABETIC MEDICINE, 2014, 31 : 129 - 129
  • [30] Residual C-peptide is associated with new and persistent impaired awareness of hypoglycaemia in type 1 diabetes
    Varkevisser, R.
    Sas, T.
    Aanstoot, H. -J.
    Wolffenbuttel, B.
    van der Klauw, M.
    DIABETOLOGIA, 2024, 67 : S58 - S58